Canine bone marrow mesenchymal stromal cells with lentiviral mHCN4 gene transfer create cardiac pacemakers

References

• Miake J, Marban E, Nuss HB. Biological pacemaker created by gene transfer. Nature. 2002;419:132–3.
   PubMed Web of Science ®Google Scholar
• Edelberg JM, Aird WC, Rosenberg RD. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest. 1998;101:337–43.
   PubMed Web of Science ®Google Scholar
• Qu J, Plotnikov AN, Danilo P Jr, Shlapakova I, Cohen IS, Robinson RB, . Expression and function of a biological pacemaker in canine heart. Circulation. 2003;107:1106–9.
   PubMed Web of Science ®Google Scholar
• Plotnikov AN, Sosunov EA, Qu J, Shlapakova IN, Anyukhovsky EP, Liu L, . Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation. 2004;109:506–12.
   PubMed Web of Science ®Google Scholar
• Potapova I, Plotnikov A, Lu Z, Danilo P Jr, Valiunas V, Qu J, . Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res. 2004;94:952–9.
   PubMed Web of Science ®Google Scholar
• Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P Jr, Lorell BH, Potapova IA, . Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706–13.
   PubMedGoogle Scholar
• Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, . Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation. 2005;111:11–20.
   PubMed Web of Science ®Google Scholar
• Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, . Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22:1282–9.
   PubMed Web of Science ®Google Scholar
• Seppen J, Barry SC, Harder B, Osborne WR. Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin. Blood. 2001;98:594–6.
   PubMed Web of Science ®Google Scholar
• DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res. 2010;106:434–46.
   PubMed Web of Science ®Google Scholar
• Boink GJ, Verkerk AO, van Amersfoorth SC, Tasseron SJ, van der Rijt R, Bakker D, . Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer. J Gene Med. 2008;10:487–97.
   PubMedGoogle Scholar
• Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009;4:102–6.
   PubMed Web of Science ®Google Scholar
• Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462–71.
   PubMed Web of Science ®Google Scholar
• Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, . Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402–16.
   PubMed Web of Science ®Google Scholar
• Seifert R, Scholten A, Gauss R, Mincheva A, Lichter P, Kaupp UB. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc Natl Acad Sci USA. 1999;96:9391–6.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Zong X, Stieber J, Hullin R, Hofmann F, Biel M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 1999;18:2323–9.
   PubMed Web of Science ®Google Scholar
• Rosenshtraukh L, Danilo P Jr, Anyukhovsky EP, Steinberg SF, Rybin V, Brittain-Valenti K, . Mechanisms for vagal modulation of ventricular repolarization and of coronary occlusion-induced lethal arrhythmias in cats. Circ Res. 1994;75:722–32.
   PubMedGoogle Scholar
• Altomare C, Terragni B, Brioschi C, Milanesi R, Pagliuca C, Viscomi C, . Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node. J Physiol. 2003;549:347–59.
   PubMedGoogle Scholar
• Baruscotti M, Bucchi A, Difrancesco D. Physiology and pharmacology of the cardiac pacemaker (‘funny’) current. Pharmacol Ther. 2005;107:59–79.
   PubMed Web of Science ®Google Scholar
• DiFrancesco D. Block and activation of the pace-maker channel in calf purkinje fibres: effects of potassium, caesium and rubidium. J Physiol. 1982;329:485–507.
   PubMed Web of Science ®Google Scholar
• Edelberg JM, Huang DT, Josephson ME, Rosenberg RD. Molecular enhancement of porcine cardiac chronotropy. Heart. 2001;86:559–62.
   PubMed Web of Science ®Google Scholar
• Chedrawy EG, Wang JS, Nguyen DM, Shum-Tim D, Chiu RC. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements. J Thorac Cardiovasc Surg. 2002;124:584–90.
   PubMedGoogle Scholar
• Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, . Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol. 2004;555:617–26.
   PubMed Web of Science ®Google Scholar
• Zhang XY, La Russa VF, Bao L, Kolls J, Schwarzenberger P, Reiser J. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther. 2002;5:555–65.
   PubMed Web of Science ®Google Scholar
• Kinkaid HY, Huang XP, Li RK, Weisel RD. What's new in cardiac cell therapy? Allogeneic bone marrow stromal cells as ‘universal donor cells’. J Card Surg. 2010;25:359–66.
   PubMed Web of Science ®Google Scholar
• Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, Popovic ZB, . Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol. 2007; 42:304–14.
   PubMed Web of Science ®Google Scholar
• Asari S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, . Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol. 2009;37:604–15.
   PubMed Web of Science ®Google Scholar
• Fibbe WE, Nauta AJ, Roelofs H. Modulation of immune responses by mesenchymal stem cells. Ann NY Acad Sci. 2007;1106:272–8.
   PubMed Web of Science ®Google Scholar